Allan Marchington

Allan Marchington is a seasoned professional in the life sciences sector, currently serving as Managing Director and Head of Life Sciences at Intermediate Capital Group (ICG) since January 2021, while also holding the position of Managing Partner at Bridge Valley Ventures since January 2019, focusing on global investments in life sciences. As a Partner and founding member of Apposite Capital, a healthcare venture capital firm established in 2005, Allan Marchington plays a pivotal role in leading investments. Additionally, involvement as a Non-Executive Board Member across various companies, including Birdrock Bio and previously Ambrx and Convergence Pharmaceuticals, highlights substantial governance experience. Educationally, Allan Marchington earned a PhD in Synthetic Chemistry from the University of Liverpool, reflecting a strong academic background.